Greten TF OL, Fikuart A, Hochst B, Henschen S, Horning M, Manns MP, Korangy F. Low -dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T -cell responses in patients with advanced HCC. J Immunother 2010;33:211-8.